These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


281 related items for PubMed ID: 34463208

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. LncRNA PCBP1-AS1 suppresses cell growth in oral squamous cell carcinoma by targeting miR-34c-5p/ZFP36 axis.
    Shafiee Allaf O, Li W, Zeng C, Li P, Zhang Y, Xu Y, Bao B.
    Cell Mol Biol (Noisy-le-grand); 2024 Oct 08; 70(9):99-105. PubMed ID: 39380272
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. MiR-223-3p inhibits proliferation and metastasis of oral squamous cell carcinoma by targeting SHOX2.
    Sun C, Liu XH, Sun YR.
    Eur Rev Med Pharmacol Sci; 2019 Aug 08; 23(16):6927-6934. PubMed ID: 31486492
    [Abstract] [Full Text] [Related]

  • 26. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X, Yang B, Liu F, Fang Q.
    Biomed Pharmacother; 2020 Jan 08; 121():109623. PubMed ID: 31731187
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p.
    Liu C, Wang JO, Zhou WY, Chang XY, Zhang MM, Zhang Y, Yang XH.
    Mol Cell Endocrinol; 2019 Aug 01; 493():110424. PubMed ID: 30991076
    [Abstract] [Full Text] [Related]

  • 29. Upregulation of miR-519d-3p Inhibits Viability, Proliferation, and G1/S Cell Cycle Transition of Oral Squamous Cell Carcinoma Cells Through Targeting CCND1.
    Zhang W, Hong W.
    Cancer Biother Radiopharm; 2024 Mar 01; 39(2):153-163. PubMed ID: 33052706
    [Abstract] [Full Text] [Related]

  • 30. Circ_0008068 facilitates the oral squamous cell carcinoma development by microRNA-153-3p/acylgycerol kinase (AGK) axis.
    Long Y, Li C, Zhu B.
    Bioengineered; 2022 May 01; 13(5):13055-13069. PubMed ID: 35635053
    [Abstract] [Full Text] [Related]

  • 31. Long non-coding RNA C5orf66-AS1 prevents oral squamous cell carcinoma through inhibiting cell growth and metastasis.
    Lu T, Liu H, You G.
    Int J Mol Med; 2018 Dec 01; 42(6):3291-3299. PubMed ID: 30280186
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. CircKRT1 drives tumor progression and immune evasion in oral squamous cell carcinoma by sponging miR-495-3p to regulate PDL1 expression.
    Yang Z, Chen W, Wang Y, Qin M, Ji Y.
    Cell Biol Int; 2021 Jul 01; 45(7):1423-1435. PubMed ID: 33675276
    [Abstract] [Full Text] [Related]

  • 36. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
    Li H, Jiang J.
    J Investig Med; 2020 Oct 01; 68(7):1282-1288. PubMed ID: 32690597
    [Abstract] [Full Text] [Related]

  • 37. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L, Hou TJ, Yang P.
    Eur Rev Med Pharmacol Sci; 2019 Aug 01; 23(15):6505-6515. PubMed ID: 31378890
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.